HAEMONETICS CORP·4

Sep 17, 11:47 AM ET

FORISH JOSEPH J 4

4 · HAEMONETICS CORP · Filed Sep 17, 2012

Insider Transaction Report

Form 4
Period: 2012-09-13
FORISH JOSEPH J
VP, Human Resources
Transactions
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2012-09-135,3730 total
    Exercise: $52.76From: 2007-05-05Exp: 2013-05-05Common Stock (5,373 underlying)
  • Sale

    Common Stock

    2012-09-13$80.00/sh5,373$429,8408,497 total
  • Exercise/Conversion

    Common Stock

    2012-09-13$52.76/sh+5,373$283,47913,870 total
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $51.07From: 2008-10-24Exp: 2014-10-24Common Stock (11,799 underlying)
    11,799
  • Non-Qualified Stock Option (right to buy)

    Exercise: $54.55From: 2009-10-22Exp: 2015-10-22Common Stock (11,911 underlying)
    11,911
  • Non-Qualified Stock Option (right to buy)

    Exercise: $61.34From: 2012-10-25Exp: 2018-10-25Common Stock (15,370 underlying)
    15,370
  • Non-Qualified Stock Option (right to buy)

    Exercise: $52.94From: 2010-10-27Exp: 2016-10-27Common Stock (14,690 underlying)
    14,690
  • Non-Qualified Stock Option (right to buy)

    Exercise: $54.99From: 2011-10-27Exp: 2017-10-27Common Stock (15,388 underlying)
    15,388
Footnotes (3)
  • [F1]Pursuant to a 10b5-1 Plan.
  • [F2]Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
  • [F3]Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT